Genscript Biotech Corp
HKEX:1548

Watchlist Manager
Genscript Biotech Corp Logo
Genscript Biotech Corp
HKEX:1548
Watchlist
Price: 14.62 HKD 8.78% Market Closed
Market Cap: 31.8B HKD

Intrinsic Value

The intrinsic value of one Genscript Biotech Corp stock under the Base Case scenario is 13.54 HKD. Compared to the current market price of 14.62 HKD, Genscript Biotech Corp is Overvalued by 7%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
13.54 HKD
Overvaluation 7%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Genscript Biotech Corp

Valuation History Unavailable

Historical valuation for Genscript Biotech Corp cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Genscript Biotech Corp?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Genscript Biotech Corp
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Genscript Biotech Corp

Current Assets 2.4B
Cash & Short-Term Investments 1.9B
Receivables 299.5m
Other Current Assets 125.5m
Non-Current Assets 1B
Long-Term Investments 90.8m
PP&E 750.9m
Intangibles 20m
Other Non-Current Assets 172.4m
Efficiency

Free Cash Flow Analysis
Genscript Biotech Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Genscript Biotech Corp

Revenue
594.5m USD
Cost of Revenue
-322.4m USD
Gross Profit
272.1m USD
Operating Expenses
-380.8m USD
Operating Income
-108.6m USD
Other Expenses
3.1B USD
Net Income
3B USD
Fundamental Scores

Profitability Score
Profitability Due Diligence

Genscript Biotech Corp's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

48/100
Profitability
Score

Genscript Biotech Corp's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Genscript Biotech Corp's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Negative Net Debt
Low D/E
68/100
Solvency
Score

Genscript Biotech Corp's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Genscript Biotech Corp

Wall Street analysts forecast Genscript Biotech Corp stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Genscript Biotech Corp is 24.36 HKD with a low forecast of 17.78 HKD and a high forecast of 30.45 HKD.

Lowest
Price Target
17.78 HKD
22% Upside
Average
Price Target
24.36 HKD
67% Upside
Highest
Price Target
30.45 HKD
108% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Genscript Biotech Corp is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Genscript Biotech Corp stock?

The intrinsic value of one Genscript Biotech Corp stock under the Base Case scenario is 13.54 HKD.

Is Genscript Biotech Corp stock undervalued or overvalued?

Compared to the current market price of 14.62 HKD, Genscript Biotech Corp is Overvalued by 7%.

Back to Top